LGND - LIGAND PHARMACEUTICALS INC
208.95
4.710 2.254%
Share volume: 189,218
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$204.24
4.71
0.02%
Summary score
20%
Profitability
21%
Dept financing
11%
Liquidity
75%
Performance
6%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
5.11%
Return on assets
1.65%
Return on sales
30.24%
Return on invested capital
23.76%
Total debt ratio
46.66%
Debt ratio change over timeo
0%
Current Ratio
14.51%
Quick Ratio
14.4%
Cash Position Ratio
2.31%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-0.6%
Return on assets
0.13%
Return on sales
0.09%
Return on invested capital
-1.23%
Total debt ratio
45.25%
Debt ratio change over timeo
0%
Current Ratio
39.13%
Quick Ratio
38.82%
Cash Position Ratio
6.2%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-0.96%
Return on assets
0.3%
Return on sales
8.95%
Return on invested capital
-1.93%
Total debt ratio
44.06%
Debt ratio change over time
0%
Current Ratio
20.28%
Quick Ratio
19.96%
Cash Position Ratio
10.81%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LGND | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 5.11% | 18.71% | 4.67% | -3.65% |
| Return on assets | 1.65% | 3.4% | 3.32% | 3.5% |
| Return on sales | 30.24% | 24.27% | 25.81% | 31.31% |
| Return on invested capital | 23.76% | 5.38% | 4.17% | 4.99% |
| Profitability | 68% | 74% | 55% | 55% |
| Total debt ratio | 46.66% | 78.91% | 58.54% | 101.15% |
| Debt ratio change over time | 0% | 0% | 10.69% | 52.18% |
| Dept financing | 12% | 20% | 20% | 50% |
| Current Ratio | 39.13% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 38.82% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 6.2% | 0.21% | 0.6% | 1.41% |
| Liquididy | 75% | 8% | 11% | 13% |
| Short-term ratios | LGND | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -0.6% | 41.05% | 6.87% | -16.17% |
| Return on assets | 0.13% | 3.67% | 3.13% | 2.71% |
| Return on sales | 0.09% | 26.16% | 24.75% | 29.9% |
| Return on invested capital | -1.23% | 9.43% | 5.58% | 6.54% |
| Profitability | 1% | 97% | 61% | 61% |
| Total debt ratio | 45.25% | 91.28% | 61.3% | 99.31% |
| Debt ratio change over time | 0% | 0% | 13.89% | -24.55% |
| Dept financing | 11% | 23% | 40% | 25% |
| Current Ratio | 39.13% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 38.82% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 6.2% | 0.21% | 0.6% | 1.41% |
| Liquididy | 75% | 2% | 4% | 8% |